| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cerebellum development | 1.42e-05 | 139 | 46 | 5 | GO:0021549 | |
| GeneOntologyBiologicalProcess | metencephalon development | 2.26e-05 | 153 | 46 | 5 | GO:0022037 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 2.34e-05 | 713 | 46 | 9 | GO:0048598 | |
| GeneOntologyBiologicalProcess | hindbrain development | 9.73e-05 | 208 | 46 | 5 | GO:0030902 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 NAV2 ZCCHC14 MLLT6 PHLDB1 TANC1 TNFAIP3 GAREM2 GLI1 SGSM2 TPCN1 BAHCC1 | 2.42e-08 | 1105 | 48 | 12 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 NAV2 ZCCHC14 PHLDB1 TANC1 TNFAIP3 LATS1 NFATC3 PALLD GLCCI1 | 2.29e-07 | 861 | 48 | 10 | 36931259 |
| Pubmed | 2.94e-07 | 10 | 48 | 3 | 21681751 | ||
| Pubmed | ISL1/SHH/CXCL12 signaling regulates myogenic cell migration during mouse tongue development. | 1.65e-06 | 17 | 48 | 3 | 36196625 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21068316 | ||
| Pubmed | Gli regulates MUC5AC transcription in human gastrointestinal cells. | 1.87e-06 | 2 | 48 | 2 | 25166306 | |
| Pubmed | Evolutionarily conserved Tbx5-Wnt2/2b pathway orchestrates cardiopulmonary development. | 1.98e-06 | 18 | 48 | 3 | 30352852 | |
| Pubmed | 2.35e-06 | 19 | 48 | 3 | 26235047 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 3.64e-06 | 908 | 48 | 9 | 19274049 | |
| Pubmed | RNA-binding proteins RBM20 and PTBP1 regulate the alternative splicing of FHOD3. | 5.59e-06 | 3 | 48 | 2 | 30468920 | |
| Pubmed | Tanc1/2 TPR domain interacts with Myo18a C-terminus and undergoes liquid-liquid phase separation. | 5.59e-06 | 3 | 48 | 2 | 38092135 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 20972463 | ||
| Pubmed | 2.35e-05 | 40 | 48 | 3 | 32317081 | ||
| Pubmed | Cooperative synergy between NFAT and MyoD regulates myogenin expression and myogenesis. | 2.79e-05 | 6 | 48 | 2 | 18676376 | |
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 21283718 | ||
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 26882546 | ||
| Pubmed | Loss of sonic hedgehog gene leads to muscle development disorder and megaesophagus in mice. | 8.33e-05 | 10 | 48 | 2 | 29768039 | |
| Pubmed | VEGF receptor 2 (KDR) protects airways from mucus metaplasia through a Sox9-dependent pathway. | 1.02e-04 | 11 | 48 | 2 | 34010630 | |
| Pubmed | E2f4 is required for normal development of the airway epithelium. | 1.02e-04 | 11 | 48 | 2 | 17383628 | |
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 28506991 | ||
| Pubmed | 1.14e-04 | 808 | 48 | 7 | 20412781 | ||
| Pubmed | The novel ciliogenesis regulator DYRK2 governs Hedgehog signaling during mouse embryogenesis. | 1.22e-04 | 12 | 48 | 2 | 32758357 | |
| Pubmed | An Hh-dependent pathway in lateral plate mesoderm enables the generation of left/right asymmetry. | 1.22e-04 | 12 | 48 | 2 | 19879143 | |
| Pubmed | Conditional stabilization of beta-catenin expands the pool of lung stem cells. | 1.44e-04 | 13 | 48 | 2 | 18356571 | |
| Pubmed | Cilia-dependent GLI processing in neural crest cells is required for tongue development. | 1.68e-04 | 14 | 48 | 2 | 28286175 | |
| Pubmed | Insight into the Etiology of Undifferentiated Soft Tissue Sarcomas from a Novel Mouse Model. | 1.68e-04 | 14 | 48 | 2 | 30683671 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.89e-04 | 877 | 48 | 7 | 20211142 | |
| Pubmed | Gli2 and Gli3 have redundant and context-dependent function in skeletal muscle formation. | 1.94e-04 | 15 | 48 | 2 | 15604102 | |
| Pubmed | β-Catenin-SOX2 signaling regulates the fate of developing airway epithelium. | 1.94e-04 | 15 | 48 | 2 | 22421361 | |
| Pubmed | 1.94e-04 | 15 | 48 | 2 | 25358791 | ||
| Pubmed | Kinome siRNA screen identifies regulators of ciliogenesis and hedgehog signal transduction. | 1.94e-04 | 15 | 48 | 2 | 18827223 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.19e-04 | 398 | 48 | 5 | 35016035 | |
| Pubmed | GATA4 and GATA6 regulate pancreatic endoderm identity through inhibition of hedgehog signaling. | 2.21e-04 | 16 | 48 | 2 | 26932670 | |
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 19304890 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 2.35e-04 | 218 | 48 | 4 | 33378226 | |
| Pubmed | Foxf genes integrate tbx5 and hedgehog pathways in the second heart field for cardiac septation. | 2.50e-04 | 17 | 48 | 2 | 25356765 | |
| Pubmed | 2.65e-04 | 225 | 48 | 4 | 12168954 | ||
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 36057966 | ||
| Pubmed | Primary cilia maintain corneal epithelial homeostasis by regulation of the Notch signaling pathway. | 3.14e-04 | 19 | 48 | 2 | 27122169 | |
| Pubmed | 3.14e-04 | 19 | 48 | 2 | 25043473 | ||
| Pubmed | Cell-autonomous activation of Hedgehog signaling inhibits brown adipose tissue development. | 3.14e-04 | 19 | 48 | 2 | 25848030 | |
| Pubmed | 3.49e-04 | 20 | 48 | 2 | 26252542 | ||
| Pubmed | 3.49e-04 | 20 | 48 | 2 | 18990706 | ||
| Pubmed | Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome. | 3.49e-04 | 20 | 48 | 2 | 7588068 | |
| Pubmed | 3.85e-04 | 102 | 48 | 3 | 19741146 | ||
| Pubmed | 4.16e-04 | 709 | 48 | 6 | 22988430 | ||
| Pubmed | 4.23e-04 | 22 | 48 | 2 | 34998785 | ||
| Pubmed | Hedgehog signaling controls mesenchymal growth in the developing mammalian digestive tract. | 4.23e-04 | 22 | 48 | 2 | 20430747 | |
| Pubmed | 4.23e-04 | 22 | 48 | 2 | 24301466 | ||
| Pubmed | ATMIN is a transcriptional regulator of both lung morphogenesis and ciliogenesis. | 4.23e-04 | 22 | 48 | 2 | 25294941 | |
| Pubmed | Genome-wide Identification of Foxf2 Target Genes in Palate Development. | 4.63e-04 | 23 | 48 | 2 | 32040930 | |
| Pubmed | Cis-Repression of Foxq1 Expression Affects Foxf2-Mediated Gene Expression in Palate Development. | 4.63e-04 | 23 | 48 | 2 | 33898467 | |
| Pubmed | 5.05e-04 | 24 | 48 | 2 | 35322202 | ||
| Pubmed | Hedgehog signalling controls sinoatrial node development and atrioventricular cushion formation. | 5.05e-04 | 24 | 48 | 2 | 34062094 | |
| Pubmed | 5.05e-04 | 24 | 48 | 2 | 32497091 | ||
| Pubmed | 5.48e-04 | 25 | 48 | 2 | 12421714 | ||
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 6.40e-04 | 27 | 48 | 2 | 21791528 | |
| Pubmed | 6.40e-04 | 27 | 48 | 2 | 25631042 | ||
| Pubmed | 6.40e-04 | 27 | 48 | 2 | 15075292 | ||
| Pubmed | Excess neuropeptides in lung signal through endothelial cells to impair gas exchange. | 6.40e-04 | 27 | 48 | 2 | 35303432 | |
| Pubmed | A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth. | 6.89e-04 | 28 | 48 | 2 | 25912685 | |
| Pubmed | The small GTPase RSG1 controls a final step in primary cilia initiation. | 6.89e-04 | 28 | 48 | 2 | 29038301 | |
| Pubmed | 6.89e-04 | 28 | 48 | 2 | 35112129 | ||
| Pubmed | 7.39e-04 | 29 | 48 | 2 | 28797033 | ||
| Pubmed | 7.39e-04 | 29 | 48 | 2 | 27120339 | ||
| Pubmed | 8.45e-04 | 31 | 48 | 2 | 30153454 | ||
| Pubmed | 8.45e-04 | 31 | 48 | 2 | 36362374 | ||
| Pubmed | 8.45e-04 | 31 | 48 | 2 | 30305289 | ||
| Pubmed | 8.45e-04 | 31 | 48 | 2 | 21985497 | ||
| Pubmed | The NANCI-Nkx2.1 gene duplex buffers Nkx2.1 expression to maintain lung development and homeostasis. | 9.01e-04 | 32 | 48 | 2 | 28546511 | |
| Pubmed | Lhx2 is a direct NF-κB target gene that promotes primary hair follicle placode down-growth. | 9.58e-04 | 33 | 48 | 2 | 26952977 | |
| Pubmed | The loss of Hoxa5 function promotes Notch-dependent goblet cell metaplasia in lung airways. | 9.58e-04 | 33 | 48 | 2 | 23213461 | |
| Pubmed | 9.58e-04 | 33 | 48 | 2 | 30914320 | ||
| Pubmed | 9.67e-04 | 140 | 48 | 3 | 26930384 | ||
| Pubmed | ISLET1-Dependent β-Catenin/Hedgehog Signaling Is Required for Outgrowth of the Lower Jaw. | 1.08e-03 | 35 | 48 | 2 | 28069742 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.12e-03 | 857 | 48 | 6 | 25609649 | |
| Pubmed | YAP/TAZ and Hedgehog Coordinate Growth and Patterning in Gastrointestinal Mesenchyme. | 1.14e-03 | 36 | 48 | 2 | 28943241 | |
| Pubmed | 1.14e-03 | 36 | 48 | 2 | 27736991 | ||
| Pubmed | Epithelial heparan sulfate regulates Sonic Hedgehog signaling in lung development. | 1.14e-03 | 36 | 48 | 2 | 28859094 | |
| Interaction | YWHAH interactions | TANC2 NAV2 ZCCHC14 NCOA1 PHLDB1 TANC1 TNFAIP3 LATS1 NFATC3 PALLD GLCCI1 | 3.51e-05 | 1102 | 47 | 11 | int:YWHAH |
| Interaction | SOX7 interactions | 3.97e-05 | 82 | 47 | 4 | int:SOX7 | |
| Cytoband | 9p13.2 | 1.62e-04 | 18 | 48 | 2 | 9p13.2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.84e-07 | 159 | 48 | 5 | 50d951cf27a571c0c5002003c16fbc370fa17eb1 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.30e-06 | 198 | 48 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-06 | 200 | 48 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-05 | 153 | 48 | 4 | 79c4f4ccdc8249c8461075c73491bc3b2d13344a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.29e-05 | 169 | 48 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.36e-05 | 170 | 48 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-05 | 179 | 48 | 4 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.29e-05 | 181 | 48 | 4 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 4.29e-05 | 181 | 48 | 4 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.48e-05 | 183 | 48 | 4 | 4617b18da8d699a44e4c47980197b1e7eb951470 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.58e-05 | 184 | 48 | 4 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.67e-05 | 185 | 48 | 4 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 4.87e-05 | 187 | 48 | 4 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 5.08e-05 | 189 | 48 | 4 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 5.08e-05 | 189 | 48 | 4 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.08e-05 | 189 | 48 | 4 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 5.18e-05 | 190 | 48 | 4 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 5.18e-05 | 190 | 48 | 4 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 5.18e-05 | 190 | 48 | 4 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 5.29e-05 | 191 | 48 | 4 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 5.29e-05 | 191 | 48 | 4 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.29e-05 | 191 | 48 | 4 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | c47df468cf78a90929913c9022e8078a53cdf680 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 5.40e-05 | 192 | 48 | 4 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.51e-05 | 193 | 48 | 4 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 5.62e-05 | 194 | 48 | 4 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 5.73e-05 | 195 | 48 | 4 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 195 | 48 | 4 | f41a68b7c2621594db8d8952e301eeadc96be26f | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.73e-05 | 195 | 48 | 4 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-05 | 196 | 48 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | proximal-mesenchymal-Myofibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.97e-05 | 197 | 48 | 4 | ab21baea931ff134cf5a7ee369c091230988108b | |
| ToppCell | proximal-mesenchymal-Myofibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.97e-05 | 197 | 48 | 4 | 15f2f169758a07143fc7d1bdb58d0b4d750a0be4 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 5.97e-05 | 197 | 48 | 4 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.97e-05 | 197 | 48 | 4 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.97e-05 | 197 | 48 | 4 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 5.97e-05 | 197 | 48 | 4 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.97e-05 | 197 | 48 | 4 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | proximal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.97e-05 | 197 | 48 | 4 | c59b64674fb4aaa945c1df7e4a9a3605c7cd2b75 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.97e-05 | 197 | 48 | 4 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.08e-05 | 198 | 48 | 4 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.08e-05 | 198 | 48 | 4 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.08e-05 | 198 | 48 | 4 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.33e-05 | 200 | 48 | 4 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | ASK454-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.32e-04 | 16 | 48 | 2 | ff4b903715c12587dcf6451ed8bc070207858143 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|RV / Chamber and Cluster_Paper | 1.98e-04 | 105 | 48 | 3 | 49e16b11f16e83a7d17d162c14bce991201bcc2a | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-04 | 107 | 48 | 3 | 410b37beffaf637a2a64c9d0ce7baf81f4bc667c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-04 | 107 | 48 | 3 | 5bae4b3aede9bcbf7e88414e3453973cc8b0c3e7 | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HT_HG-U133A | 3.29e-06 | 199 | 47 | 6 | 6287_UP | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 4.90e-04 | 21 | 46 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | activities of daily living score measurement | 4.90e-04 | 21 | 46 | 2 | EFO_0008451 | |
| Disease | right ventricular systolic volume measurement | 1.37e-03 | 35 | 46 | 2 | EFO_0021815 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.67e-03 | 49 | 46 | 2 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Acute Cerebrovascular Accidents | 3.23e-03 | 54 | 46 | 2 | C0751956 | |
| Disease | abdominal fat cell number | 3.65e-03 | 198 | 46 | 3 | EFO_0021534 | |
| Disease | urate measurement, spine bone mineral density | 3.72e-03 | 58 | 46 | 2 | EFO_0004531, EFO_0007701 | |
| Disease | blood osmolality measurement | 3.72e-03 | 58 | 46 | 2 | EFO_0007967 | |
| Disease | adverse effect, response to xenobiotic stimulus | 3.84e-03 | 59 | 46 | 2 | EFO_0009658, GO_0009410 | |
| Disease | Sjogren syndrome | 3.97e-03 | 60 | 46 | 2 | EFO_0000699 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 4.10e-03 | 61 | 46 | 2 | DOID:3587 (is_marker_for) | |
| Disease | Cerebrovascular accident | 4.24e-03 | 62 | 46 | 2 | C0038454 | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.51e-03 | 64 | 46 | 2 | DOID:4947 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSSHCSPSPTSSRGT | 536 | Q8IVW6 | |
| SPPACSSSSSSLFSA | 161 | P50548 | |
| TSSEDPHSGCPSRSS | 811 | P55198 | |
| PHSGCPSRSSSSLSF | 816 | P55198 | |
| SLGSAASTHPSGPSS | 81 | Q9P281 | |
| RSSSCSSHSPCVSPF | 356 | Q86VQ1 | |
| SSSISSSSGSPYHPC | 401 | Q15517 | |
| SSSGSPYHPCGSASQ | 406 | Q15517 | |
| SFTSCSSSHSPPGPS | 651 | Q5T481 | |
| NSSKSTSSFPCPAGH | 551 | Q08380 | |
| SSSAPAQSSPSSGHE | 436 | O95835 | |
| PPSSSSSSCCSPHTG | 76 | Q8WY41 | |
| CPSAASSPHTSSPTF | 771 | P56645 | |
| SHGSPAPSTSSTCRL | 636 | Q14123 | |
| SSSSSGPRVSGSPCH | 356 | Q5QP82 | |
| SPGAQSSCSSDHSPA | 441 | P08151 | |
| GCHMTSTPGSTSSSP | 1846 | P98088 | |
| ASGHGTPASSPSSSS | 746 | Q8WX93 | |
| AASSSASTPHCSNPG | 961 | Q5SYB0 | |
| SSASHGLCSSPAEPS | 166 | Q2WGN9 | |
| ACLAPLSHSPSSSDS | 521 | Q2V2M9 | |
| HTPGKPTSSCTSRSA | 86 | Q92949 | |
| SSDLSPTFGHCLPSS | 36 | Q3LI83 | |
| SPSSSAHSGFRTPCL | 66 | Q8NAJ2 | |
| GSSSSCSSASLPASP | 186 | Q9NQR7 | |
| PSSSPASASTVSHIC | 96 | Q16478 | |
| TSDCPHSSSSSDGPA | 341 | Q9P1A2 | |
| TPSSNPAASAGLHSS | 356 | Q12947 | |
| SAAPPSSCAPSSSSS | 676 | Q75VX8 | |
| SSPGHCASLSRSTAF | 141 | Q06141 | |
| SSGSSSTSTHLNCAP | 251 | Q86TG1 | |
| SSGGSCPSSHSSLTE | 671 | Q15788 | |
| TPSPSASSHLLSPSC | 356 | Q96SF7 | |
| ASSPSSAHSAPSNSL | 1391 | Q8IVL1 | |
| SCSSSSSPHATPSHC | 461 | O43147 | |
| HPASLTSSGSSGSPS | 1656 | Q9C0D5 | |
| SAHSSITSGSCPGTP | 421 | Q9HCD6 | |
| CAPSNASSLSSSSPG | 141 | Q6NUJ2 | |
| ASSSTCASPPSLTSA | 401 | Q86XZ4 | |
| EASSSLSTSLPPSCH | 546 | P21580 | |
| PPSHSGSSSSRRSCQ | 1191 | Q6IQ55 | |
| GPSHSGSATTASPAA | 916 | Q12968 | |
| SSPSSSSPSSSCPSA | 226 | Q17RH7 | |
| SPLSSPASSGSCASH | 256 | Q86UU1 | |
| PASSGSCASHSPSGQ | 261 | Q86UU1 | |
| SASSSSSSPGSPAHG | 16 | Q8IY26 | |
| STSESHSGTLSCPSA | 136 | O15060 | |
| SLSSGGESSPSSPAH | 51 | Q9ULQ1 | |
| CANSNTASPSSHPST | 701 | Q8WYQ9 | |
| ASSGSSSCTPAGPHA | 311 | Q9H0D2 | |
| PGVPSECSSHSASCS | 156 | P15173 |